Skip to main content


October 6-8 in Boston
The Official Partner of the Clinical Pathways Congress
Business-Changing Insights, Practical Strategies, and Exchange with Innovators

The 2023 Clinical Pathways Congress is debuting a new partnership with the Cancer Care Business Exchange. Join us as we reimagine how the industry delivers and pays for cancer care.

This new collaboration expands the conversation to the stakeholders who have interest, influence, and impact on the evolving business models of cancer care and how innovation will continue to improve them.

Join us October 68 in Boston for business-changing insights, practical strategies, and key exchanges with innovators. Together we will devise practical strategies and actionable solutions to the business challenges facing today’s cancer care stakeholders.

McKinney Testimonial
Klein Testimonial
Why Should You Attend

Year after year, 97% of our attendees say the Congress increases their knowledge and meets their educational needs. Your registration includes access to insightful conversations with key opinion leaders, crucial education, meaningful networking, timely discussions with the industry’s top solution providers, and so much more.

    Leading Cancer Organizations
    Expert Presenters
    Unmatched Educational Sessions
    Conference Leaders
    Robin T. Zon, MD, FACP, FASCO
    Past Chair, ASCO Pathways Task Force
    Physician Emeritus, Finance & Quality Chair
    Michiana Hematology-Oncology, PC
    Mishawaka, Indiana
    Barry Russo, MBA
    Chief Executive Officer
    The Center for Cancer and Blood Disorders
    Fort Worth, Texas
    Andrew Hertler, MD, FACP
    Chief Medical Officer
    New Century Health
    Brea, California
    Deirdre Saulet, PhD
    Market Vice President of Oncology
    Carrum Health
    Richmond, Virginia
    Frederick M. Schnell, MD, FACP
    Chief Medical Officer
    National Cancer Treatment Alliance/Community Oncology Alliance
    Washington, DC
    Erich Mounce, MSHA
    Chief Executive Officer
    Oncology Care Partners
    La Grange, Tennessee
    Wui-Jin Koh, MD
    Senior Vice President, Chief Medical Officer
    National Comprehensive Cancer Network
    Ft. Washington, Pennsylvania
    Ronald Barkley, MS, JD
    Cancer Center Business Development Group
    Vero Beach, Florida
    Alan Balch, PhD
    Chief Executive Officer
    Patient Advocate Foundation &
    National Patient Advocate Foundation
    Hampton, Virginia
    Carla Balch, MS
    Founder and Chief Executive Officer
    Memphis, Tennessee
    Alexis Bortniker, JD
    Foley & Lardner LLP
    San Diego, California
    Nina Chavez, MBA
    Vice President of Customer Experience
    Flatiron Health
    Albuquerque, New Mexico
    Stephen B. Edge, MD, FACS, FASCO
    Vice President, Healthcare Outcomes & Policy, Professor of Surgery and Oncology, Department of Surgical Oncology, Breast Service, Roswell Park Comprehensive Cancer Center, Professor of Surgery, Jacobs School of Medicine, University at Buffalo
    Buffalo, New York
    James Hamrick, MD, MPH
    Vice President, Clinical Oncology
    Flatiron Health
    Atlanta, Georgia
    John E. Hennessy, MBA
    Valuate Health Consultancy
    Overland Park, Kansas
    Manasi Kapoor, MBA
    Market Insights Manager
    Memorial Sloan Kettering
    New York, New York
    Ira Klein, MD
    Vice President of Medical Affairs for Payer Relations
    Tempus Labs
    Chicago, Illinois
    Michael Kolodziej, MD
    Senior Advisor
    Washington, DC
    Harlan Levine, MD
    President of Health Innovation and Policy
    City of Hope
    Duarte, California
    Barbara McAneny, MD
    Chief Executive Office and Founder
    New Mexico Oncology Hematology Consultants, Ltd
    Albuquerque, New Mexico
    Mahek A. Shah, MD, MBA, MS
    Physician Executive, Investor, and Advisor
    Harvard Business School
    Associate Faculty
    Harvard School of Public Health and Brigham Health, Ariadne Labs
    Boston, Massachusetts
    Ed Rodgers
    Director of Network Development
    Pittsburgh, Pennsylvania
    Adria Warren, JD
    Foley & Lardner LLP
    Boston, Massachusetts
    Help us reimagine cancer care

    The Congress brings together the biggest names across the cancer care spectrum and provides a unique opportunity for meaningful engagement with payer- and provider-facing pathway architects. If you are interested in being a part of this year’s event, we encourage you to reach out to learn more about our partnership opportunities. Together we can unlock the potential of cancer care to deliver a brighter future for patients.

    Who Should Attend?

    This program is designed for healthcare professionals interested in learning how to implement, maintain, and measure treatment pathways.

    Oncologists, Hematologists, Oncology Pharmacists, Oncology Nurses
    Reimbursement Managers / Specialists
    Cancer Care Team Members
    Oncology Practice Managers
    Pathway Development Executives
    Commercial Payer
    Pharmacy Benefit Management Organizations
    Technology & Consultant Service Providers
    Employer Groups / Coalitions
    Oncology Practice and Health System
    Hospital Executives
    Students, Residents, & Fellows
    Excellent format featuring highly educational and entertaining sessions with experienced faculty. It is a great event for those looking for both an industry overview and in-depth information."
    As a pathways professional and health plan administrator, the Clinical Pathways Congress is the most important conference I attend each year, in terms of content and networking."
    The Clinical Pathways Congress is a great introduction into how beneficial pathways are to institutions that have already incorporated them. It was very interesting to learn how different institutions use them and how I can incorporate them into practice."

    Sign up for Updates